Archives

  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07

    • 2'3'-cGAMP (Sodium Salt): Advancing STING Agonism via REC...

    2026-03-10

    2'3'-cGAMP (Sodium Salt): Advancing STING Agonism via REC8-Modulated Innate Immunity

    Introduction

    The discovery of 2'3'-cGAMP (sodium salt) (SKU: B8362) has revolutionized the study of the cGAS-STING signaling pathway and the broader landscape of innate immune activation. As a potent, endogenous cyclic dinucleotide second messenger, 2'3'-cGAMP plays a central role in cellular defense mechanisms against pathogenic DNA, bridging innate and adaptive immunity. While prior literature has established its function as a STING agonist and its broad applications in immunotherapy, cancer biology, and antiviral innate immunity, emerging research on regulatory proteins such as REC8 now reveals a new dimension of control within these pathways. This article offers an advanced, integrative perspective, focusing on REC8-mediated regulation of STING signaling and the unique experimental advantages conferred by 2'3'-cGAMP (sodium salt) in decoding these mechanisms.

    2'3'-cGAMP (Sodium Salt): Biochemical Profile and Research Utility

    2'3'-cGAMP (cyclic [G(2',5')pA(3',5')p]; sodium salt) is synthesized endogenously by cyclic GMP-AMP synthase (cGAS) in response to cytosolic double-stranded DNA. This molecule exhibits a high binding affinity for the stimulator of interferon genes (STING) protein (Kd = 3.79 nM), surpassing other known cyclic dinucleotides such as c-di-GMP and c-di-AMP. The APExBIO formulation—offered as a solid, highly water-soluble disodium salt (≥7.56 mg/mL)—is optimized for experimental reproducibility and stability, ensuring robust performance in cell-based and in vitro assays. For optimal preservation, the compound should be stored at -20°C.

    In the laboratory, 2'3'-cGAMP (sodium salt) is indispensable for dissecting STING-mediated innate immune responses, screening STING-targeted compounds, and modeling type I interferon induction in various cellular systems. Its utility extends to immunotherapy research, cancer immunotherapy development, and antiviral innate immunity studies, thereby serving as a cornerstone for translational investigations.

    Mechanism of Action: cGAS-STING Pathway and Beyond

    Canonical cGAS-STING Signaling Cascade

    Upon detection of cytosolic DNA, cGAS catalyzes the formation of 2'3'-cGAMP, which diffuses to the endoplasmic reticulum where it binds and activates STING. This interaction triggers STING oligomerization and translocation, recruiting TANK-binding kinase 1 (TBK1), which then phosphorylates interferon regulatory factor 3 (IRF3). Activated IRF3 translocates to the nucleus to drive transcription of type I interferon (e.g., IFN-β) and pro-inflammatory cytokines. This cascade forms the molecular basis of STING-mediated innate immune response, crucial for antiviral defense and cancer immunosurveillance.

    REC8: A Novel Layer of Regulation in STING Agonism

    Recent findings, as highlighted by Chen et al. (see reference), introduce REC8 as a pivotal modulator of MAVS and STING stability. Traditionally recognized for its role in meiosis, REC8 was shown to interact with both MAVS (the RIG-I-like receptor adaptor for RNA sensing) and STING (the DNA sensing arm), preventing their ubiquitination and degradation. During viral infection, REC8 is upregulated via the JAK-STAT pathway, relocates to the cytoplasm, and directly stabilizes MAVS and STING, thereby promoting robust type I interferon responses. Importantly, REC8's ability to inhibit RNF5-mediated K48-linked ubiquitination of STING and MAVS links chromosomal maintenance proteins to innate antiviral signaling.

    This regulatory axis expands the functional repertoire of the cGAS-STING pathway, revealing new therapeutic and research opportunities for precise modulation of innate immunity using high-affinity STING agonists such as 2'3'-cGAMP (sodium salt).

    Comparative Analysis: 2'3'-cGAMP Versus Alternative STING Agonists

    Existing reviews—such as the perspective in "2'3'-cGAMP (Sodium Salt): Precision STING Agonist for Advanced Innate Immunity Research"—highlight the superior affinity and specificity of 2'3'-cGAMP for human STING compared to synthetic or bacterial cyclic dinucleotides. While those articles emphasize workflow optimization and translational reliability, our analysis uniquely focuses on the regulatory interplay with REC8, providing a mechanistic context for how STING agonism can be fine-tuned at the level of post-translational modification and protein stability.

    Furthermore, unlike extracellular regulatory or tumor-immune crosstalk analyses ("Decoding Extracellular Regulation of cGAS-STING Signaling"), this article delves into intracellular protein networks, offering a deeper understanding of how endogenous and synthetic STING agonists interact with cellular machinery beyond the canonical pathway.

    Advanced Applications: Dissecting REC8-STING Interactions with 2'3'-cGAMP

    Functional Dissection of Innate Immunity in Viral Infection Models

    The central finding from Chen et al. demonstrates that REC8 is a positive modulator of the innate immune response through its stabilization of STING and MAVS. In virus-infected cells, SUMOylated REC8 translocates to the cytoplasm, interacts with STING, and blocks its ubiquitination, thus sustaining interferon signaling. This mechanism is particularly relevant for studying how host cells resist vesicular stomatitis virus (VSV), Newcastle disease virus (NDV), and herpes simplex virus (HSV) infections.

    Using 2'3'-cGAMP (sodium salt) as a precise STING agonist, researchers can experimentally modulate the cGAS-STING pathway in the context of REC8 knockdown or overexpression. This approach enables the dissection of downstream effects on type I interferon induction, providing a robust platform for screening antiviral modulators and identifying potential therapeutic targets within the REC8-STING axis.

    Implications for Cancer Immunotherapy and Inflammation Research

    Given the dual roles of STING in antitumor immunity and inflammation, 2'3'-cGAMP (sodium salt) is widely employed in preclinical cancer models. Recent studies (see "Harnessing Endothelial STING for Tumor Vasculature Normalization") have focused on the tumor microenvironment and vascular normalization, but have not addressed protein-level regulation of STING stability. By integrating REC8 modulation into experimental workflows, researchers can now probe how chromosomal proteins influence tumor-immune crosstalk and the efficacy of STING-targeted immunotherapies.

    This integrated perspective provides a deeper basis for evaluating candidate drugs that modulate REC8 or STING ubiquitination, and for optimizing immunotherapeutic regimens that combine 2'3'-cGAMP with agents targeting post-translational regulatory networks.

    Experimental Design Considerations and Best Practices

    For researchers embarking on REC8-STING pathway investigations, 2'3'-cGAMP (sodium salt) from APExBIO offers several advantages:

    • High Purity and Solubility: Ensures consistent dosing and precise kinetic studies in cellular and biochemical assays.
    • Validated Potency: Facilitates dose-response experiments to quantify STING activation and interferon induction.
    • Compatibility with Genetic Manipulation: Enables combination studies with REC8 knockdown/knockout or overexpression to map causal relationships.
    Optimal storage at -20°C and dissolution in water (not ethanol or DMSO) preserve compound integrity and experimental reliability.


    Synergizing with Existing Methodologies

    While previous articles have explored extracellular cGAMP regulation (see here) and radiotherapy resistance ("Leveraging 2'3'-cGAMP to Overcome Radiotherapy Resistance"), our focus on REC8-mediated modulation offers a new experimental axis: the tuning of intracellular STING stability as a variable in innate and adaptive immune response studies.

    Conclusion and Future Outlook

    The convergence of high-affinity STING agonists such as 2'3'-cGAMP (sodium salt) and advanced understanding of regulatory proteins like REC8 heralds a new era in immunotherapy research and antiviral innate immunity. By leveraging these tools, scientists can dissect not only the initiation of type I interferon responses, but also the post-translational regulatory mechanisms that dictate cellular sensitivity to infection and tumorigenesis.

    Future work will likely focus on targeting REC8-STING interactions for therapeutic advantage, optimizing cancer immunotherapy, and developing next-generation antiviral strategies. For researchers seeking robust, reproducible, and mechanistically insightful models, 2'3'-cGAMP (sodium salt) from APExBIO remains the gold-standard reagent for probing the frontiers of innate immunity.

    Reference: Chen, S. et al. The Role of REC8 in the Innate Immune Response to Viral Infection. Journal of Virology, March 2022, Vol. 96, Issue 6, e02175-21.